Group Testing Performance Evaluation for SARS-COV-2 Massive Scale Screening and Testing
View ORCID ProfileOzkan Ufuk Nalbantoglu
doi: https://doi.org/10.1101/2020.05.02.20080390
Ozkan Ufuk Nalbantoglu
Department of Computer Engineering and Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey
Data Availability
All code is available, please contract the author at ufuknalbantoglu{at}yahoo.com
Posted May 05, 2020.
Group Testing Performance Evaluation for SARS-COV-2 Massive Scale Screening and Testing
Ozkan Ufuk Nalbantoglu
medRxiv 2020.05.02.20080390; doi: https://doi.org/10.1101/2020.05.02.20080390
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11650)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3654)
- Geriatric Medicine (343)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)